- Home
- BIVI vs RCON Comparison
BIVI vs RCON Comparison
Compare BIVI & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- RCON
- Stock Information
- Founded
- BIVI 2013
- RCON 2007
- Country
- BIVI United States
- RCON China
- Employees
- BIVI N/A
- RCON N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- RCON Oilfield Services/Equipment
- Sector
- BIVI Health Care
- RCON Energy
- Exchange
- BIVI Nasdaq
- RCON Nasdaq
- Market Cap
- BIVI 49.8M
- RCON 58.4M
- IPO Year
- BIVI N/A
- RCON 2009
- Fundamental
- Price
- BIVI $1.48
- RCON $2.11
- Analyst Decision
- BIVI Strong Buy
- RCON
- Analyst Count
- BIVI 1
- RCON 0
- Target Price
- BIVI $30.00
- RCON N/A
- AVG Volume (30 Days)
- BIVI 596.3K
- RCON 5.0K
- Earning Date
- BIVI 02-11-2025
- RCON 01-01-0001
- Dividend Yield
- BIVI N/A
- RCON N/A
- EPS Growth
- BIVI N/A
- RCON N/A
- EPS
- BIVI N/A
- RCON N/A
- Revenue
- BIVI N/A
- RCON $9,475,055.00
- Revenue This Year
- BIVI N/A
- RCON N/A
- Revenue Next Year
- BIVI N/A
- RCON $15.18
- P/E Ratio
- BIVI N/A
- RCON N/A
- Revenue Growth
- BIVI N/A
- RCON 2.59
- 52 Week Low
- BIVI $1.04
- RCON $1.26
- 52 Week High
- BIVI $33.10
- RCON $3.70
- Technical
- Relative Strength Index (RSI)
- BIVI 32.72
- RCON 45.84
- Support Level
- BIVI $1.45
- RCON $2.03
- Resistance Level
- BIVI $1.88
- RCON $2.19
- Average True Range (ATR)
- BIVI 0.16
- RCON 0.11
- MACD
- BIVI -0.01
- RCON -0.00
- Stochastic Oscillator
- BIVI 5.08
- RCON 36.04
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.